Phibro Animal Health (PAHC) Receivables - Other (2013 - 2026)
Phibro Animal Health (PAHC) posted Receivables - Other of $11.7 million for Q2 2026, up 118.69% on a QoQ basis from $5.4 million in Q1 2014.
Analysis
Phibro Animal Health (PAHC) Receivables - Other (2013 - 2026) Analysis & Trends
Phibro Animal Health has reported Receivables - Other for 3 years, with the latest figure at $11.7 million in Q2 2026.
- On a quarterly basis, Receivables - Other changed N/A year-over-year to $11.7 million in Q2 2026; TTM through Jun 2026 was $11.7 million, a N/A change from a year earlier, with the FY2026 full-year figure at $11.7 million, changed N/A from the prior year.
- Receivables - Other was $11.7 million for Q2 2026 at Phibro Animal Health, up from $5.4 million in the prior quarter.
- The five-year high for Receivables - Other was $11.7 million in Q2 2026, with the low at $11.7 million in Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Idexx Laboratories | 40.69 Bn | 40.49 Bn | 779.09 Mn |
| 2 | Zoetis | 30.63 Bn | 28.95 Bn | 1.05 Bn |
| 3 | Elanco Animal Health | 11.77 Bn | 11.24 Bn | 798.00 Mn |
| 4 | Phibro Animal Health | 1.49 Bn | 1.41 Bn | 134.40 Mn |
| 5 | Immucell | 90.19 Mn | 81.33 Mn | 2.44 Mn |
| 6 | Zhengye Biotechnology Holding | 76.23 Mn | 69.14 Mn | - |
| 7 | Global Innovative Platforms | 24.88 Mn | 24.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.70 Mn |
| Mar 31, 2014 | 5.35 Mn |
| Jun 30, 2013 | 5.35 Mn |